National Cardiac Audit Programme 2022 Report: The heart in lockdown
The National Cardiac Audit Programme (NCAP) has published its 2022 annual report. Based on data from 1 April 2020 to 31 March 2021, the report focuses on how cardiovascular services were impacted by the first year of the COVID-19 pandemic. NCAP comprises of six domains, each of which is concerned with a particular cardiovascular disease area or treatment (for which individual reports can also be found using these links):
- The National Congenital Heart Disease Audit (NCHDA)
- The Myocardial Ischaemia National Audit Project (MINAP)
- The National Audit of Percutaneous Coronary Interventions (NAPCI)
- The National Adult Cardiac Surgery Audit (NACSA)
- The National Heart Failure Audit (NHFA)
- The National Audit of Cardiac Rhythm Management (NACRM)
This annual report found that overall acute admissions were down during 2020/21, with a 9% reduction in those with STEMI, 18% fall in those with NSTEMI and a 12% fall in admissions for heart failure. Other key findings include:
- Antenatal detection of congenital heart defects requiring intervention in the first year improved to 52%
- More STEMI patients were investigated by echocardiography – now 77%
- There was increased referral of heart attack patients to cardiac rehabilitation – exceeded the 85% target at the end of 2020/21
- The mortality for most cardiac interventions remained unchanged (for example, all PCI 2%, PPCI 5.5%, and NSTEMI PCI 0.75%).
The report also found that there were substantial drops in acute cardiovascular admissions during the first wave of COVID-19 hospitalisations and, while the reductions in the second COVID-19 wave were significant, they were smaller for all procedures except for PPCI.
Read the full report: You can read the report by clicking on the link below.
Stay-up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
